People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmunoMolecular Therapeutics, Inc. | — | Biotechnology | Series A | $10.8M | $215.5M | 2020 |
| Gear Six Inc | — | Other Technology | Seed | $4.0M | $136.3M | 2009 |
Tom Shea at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tom Shea on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Dinges | 1 | 8 |
| Jonathan Behr | 1 | 4 |
| Sean Doherty | 1 | 4 |
| Brian NeSmith | 1 | 3 |
| Khaled Nasr | 1 | 3 |
| Steve Orndorff | 1 | 3 |
| R. Elliot Carpenter | 1 | 2 |
| David Liddle | 1 | 2 |
| Matthias Oberdorfer | 1 | 1 |
| Aaron Michels | 1 | 1 |
| Ed Orr | 1 | 1 |
| Peter Gottlieb | 1 | 1 |
| Nandan Padukone | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.